Organon & Co OGN 深 沪
等待开盘 09-25 09:30:00 美东时间
13.73
0.000
0.00%
华盛通- 最 高13.74
- 今 开13.73
- 成交量 86.03万股
- 最 低 13.72
- 昨 收 13.73
- 总市值 36.06亿
- 52周最高 13.785
- 市盈率 静 19.15
- 换手率 0.00%
- 52周最低 5.65
- 委 比 37.91%
- 总股本 2.63亿
- 历史最高 35.995
- 量 比 0.50
- 振 幅 0.15%
- 历史最低 5.65
- 每 手 1
- 风险率 2.98%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多DARÉ Bioscience CEO Sabrina Martucci Johnson Named to Forbes 2026 “50 Over 50: Innovation” List
Daré Bioscience CEO Sabrina Martucci Johnson has been named to Forbes' 2026 "50 Over 50: Innovation" list, recognizing her leadership in advancing women's health innovation. Daré Bioscience, founded in 2015, is dedicated to addressing unmet needs in women's health through a multi-product strategy spanning contraception, sexual health, menopause, and infectious disease. The company's portfolio includes FDA-approved products, Phase 3 clinical trial...
08-18 13:02
This House of Representative Just Sold Up To $30K In Organon Stock
A report on August 12, 2026 shows that Representative Kevin Hern from Oklahoma sale stock in Organon (NYSE:OGN), valued between $2,002 and $30,000. According to the August filing, the transaction occurred on August 5, 2026. At the time of writing, Organon shares are trading up 0.33% at $13.7. What R...
08-13 23:01
Eikon Therapeutics Reports Second Quarter 2026 Financial Results and Provides Clinical Updates
Eikon Therapeutics reported Q2 2026 financial results with $531.2 million in cash and presented seven abstracts at ESMO 2026, highlighting clinical progress across its oncology portfolio, including EIK1001, EIK1003, EIK1004, and EIK1005. The company also appointed Ma. Fatima Francisco to its Board of Directors and announced key upcoming milestones for its pipeline.
08-13 20:02
财报速睇 | Organon & Co. 2026财年Q2营收15.57亿美元，同比下降2.4%；归母净利润1.08亿美元，同比下滑25.5%
华盛资讯7月31日讯，Organon & Co.公布2026财年Q2业绩，公司Q2营收15.57亿美元，同比下降2.4%，归母净利润1.08亿美元，同比下滑25.5%。
07-31 20:32
These mid-cap stocks combine A-rated profitability with attractive forward valuations
As the market moves through second-quarter earnings season, investors are paying close attention to mid-cap stocks that combine solid profitability with attractive valuations. Forward price-to-earnin...
07-27 21:59
ORGANON CANADA ANNOUNCES THE APPOINTMENT OF DOMINIC BÉGIN AS PRESIDENT AND MANAGING DIRECTOR
25-year industry leader to drive continued growth and expand access to medicines in Canada KIRKLAND, QC, July 22, 2026 /CNW/ -- Organon Canada, a global healthcare company dedicated to impro...
07-22 20:02
Organon Issues Supplemental Disclosures on Sun Pharma Merger
Organon ( ($OGN) ) has issued an announcement. On April 26, 2026, Organon agree...
07-18 05:38
Organon To Present Phase 3 Data Of VTAMA Cream In Atopic Dermatitis At 2026 Society For Pediatric Dermatology Annual Meeting
Organon (NYSE: OGN), a global healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day, today announced that a new analysis of Phase 3 data evaluating VTAMA cream in AD will be presented at the 2026 Society for Pediatric Dermatology (SPD) Annual Meetin...
07-07 20:01
欧加农获得无激素铜宫内节育器MIUDELLA的女性健康市场独家经营权
欧加农（Organon & Co.，股票代码：OGN）达成两项业务合作：一是与塞贝拉制药（Sebela Pharmaceuticals）签署无激素铜宫内...
06-30 21:27
Record-setting healthcare M&A activity to extend through H2: PwC
Healthcare dealmaking is already at the highest level since the pandemic, and the momentum is expected to continue into H2 2026, driven by looming patent cliffs and consumer demand for areas such as w...
06-26 01:59
